Advanced Analytics

Parallel Trade Management

Impact assessment and strategy

Alira Health provides pharmaceutical and medical device companies support in assessing the impact of parallel trade on their financial performance and reputation.
We take a quantitative approach that aims to reconstruct parallel export flows at the European level. This identifies and prioritizes the markets where we may need to redefine distribution strategy and commercial agreements.

Together, we’ll work closely to design effective launch strategies aimed at managing parallel trade at the local and corporate level.

In-house training and support

We can also provide solutions designed to increase internal awareness and support sustainable performance management. Our approach includes training operational teams and consolidating reference data sources to EU-level value generation rather than country-specific volumes.

A global team of trade and data experts

When you partner with Alira Health, you gain access to a global team of data and parallel trade experts with over 15 years of pharmaceutical and medical device industry experience.

Together, we’ll build data-driven, comprehensive strategies designed to empower your company’s tools and capabilities.

Related News

Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)
Due Diligence MedTech Patient Engagement
Publications March 24, 2021
Drug Delivery Devices (DDD): Increasing Role in Patient Outcome and Future Trends, New England’s Global Appeal to Foster Collaboration
Download our newest report, Drug Delivery Devices (DDD): Increasing role in patient outcome and future trends, New England’s global appeal to foster collaboration. In this report,(...)
Research & Development
News March 15, 2021
Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical
BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm(...)
Research & Development
News March 9, 2021
A Primer on Potency Assays for Release of Biologics
A key criterion in determining the quality of a biologic product is whether it has maintained its biological activity or “potency.”
MedTech
News March 3, 2021
The 2021 MedTech Contract Manufacturing Report
Download our latest piece: The 2021 MedTech Contract Manufacturing Report. Learn how despite the ongoing pandemic, the Medical Device and CDMO industries are positioned to perform(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.